Kkr & Co. Inc.
—- Market cap
- $96.73B
- Debt
- +$328.51B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 23% equity / 77% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: KKR stock price at premium vs INCY $107.76 current versus $52.23 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at INCY's multiple
Implied fair value · at KKR's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Expensive
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: KKR FY 2025 (ended Dec 31, 2025) · INCY FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 23% equity / 77% debt
Capital structure 94% equity / 6% debt · EV / Revenue 4.62x · EV / EBITDA 13.51x
KKR carries the larger enterprise value at $425.24B against $23.74B; INCY trades on the lower EV / Revenue multiple (4.62x vs 21.85x); INCY on the lower EV / EBITDA (13.51x vs 71.04x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
KKR & CO. INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
INCYTE CORPORATION · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
10.63x
0.29x
Net debt / EBITDA
Leverage against operating earnings
—
-0.90x
Cash and equivalents
Liquid reserves on the balance sheet
—
$3.10B
Total debt
Interest-bearing obligations outstanding
$328.51B
$1.51B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BlackRock, Inc.
KKR vs BLK
Blackstone Inc.
KKR vs BX
Apollo Global Management, Inc.
KKR vs APO
Carlyle Group Inc.
KKR vs CG
Ares Management Corp
KKR vs ARES
AMGEN INC
KKR vs AMGN
GILEAD SCIENCES, INC.
KKR vs GILD
VERTEX PHARMACEUTICALS INC / MA
KKR vs VRTX
REGENERON PHARMACEUTICALS, INC.
KKR vs REGN
BIOGEN INC.
KKR vs BIIB
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.